London · Delayed Price · Currency is GBP · Price in EUR Medios AG Company Description
Medios AG, together with its subsidiaries, supplies specialty pharmaceutical drugs primarily in Germany.
The company operates through three segments: Patient-Specific Therapies; International Business; and Pharmaceutical Supply.
The Patient-Specific Therapies segment manufactures medications for patients on behalf of pharmacies.
This segment includes cytostatic preparations, antibody therapies, and parenteral nutrition solutions.
The International Business International covers all activities in the international environment from the procurement of Active Pharmaceutical Ingredients, the sterile and non-sterile drugs and the supply of public and hospital pharmacies through homecare service.
The Pharmaceutical Supply segment offers products on oncology, neurology, autoimmunology, ophthalmology, infectiology, and hemophilia diseases.
Medios AG is headquartered in Berlin, Germany.
| Country | Germany |
| Founded | 2016 |
| Industry | Medical - Equipment & Services |
| Sector | Healthcare |
| Employees | 952 |
| CEO | Matthias Gaertner |
Contact Details
Address: Heidestrasse 9 Berlin, 10557 Germany | |
| Phone | 49 30 232 5668 00 |
| Website | medios.ag |
Stock Details
| Ticker Symbol | 0QB4 |
| Exchange | London Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | DE000A1MMCC8 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Matthias Gaertner | Chief Executive Officer and Chairman of the Executive Board |
| Dr. Yann Samson | Chairman of Supervisory Board and Sustainability Officer |
| Falk Neukirch | Chief Financial Officer and Member of Executive Board |
| Christoph Prußeit | Chief Innovation Officer and Member of Executive Board |
| Mi-Young Miehler | Chief Operating Officer and Member of Executive Board |
| Claudia Nickolaus | Head of Investor and Public Relations |